Candriam Luxembourg S.C.A. »

Blueprint Medicines shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.6M 50k 92.24
2023-09-30 $6.8M 135k 50.22
2023-06-30 $9.6M 151k 63.33
2023-03-31 $19M 454k 41.41
2022-12-31 $11M 258k 43.81
2022-09-30 $26M 258k 100.00
2022-06-30 $13M 257k 50.51
2022-03-31 $12M 189k 63.88
2021-12-31 $38M 352k 107.11
2021-09-30 $24M 313k 76.92
2021-06-30 $24M 313k 76.92
2021-03-31 $25M 352k 71.43
2020-12-31 $40M 352k 112.15
2020-09-30 $50M 534k 92.70
2020-06-30 $63M 879k 71.43
2020-03-31 $8.7M 111k 78.32
2019-12-31 $8.9k 111k 0.08
2018-09-30 $3.5M 45k 78.07
2018-06-30 $2.8M 44k 63.48
2018-03-31 $4.0M 44k 91.70
2017-12-31 $3.3M 44k 75.41